"The Effect of Inhaler Lavender, Focus and Music on Women's Pain, Anxiety, in Intrauterine Device Application"

Sponsor
Turkish Ministry of Health, Kahramanmaras Provincial Health Directorate (Other)
Overall Status
Recruiting
CT.gov ID
NCT06110871
Collaborator
(none)
240
1
4
2.4
101.5

Study Details

Study Description

Brief Summary

Randomized control is an experimental study. The purpose of this research; To examine the effects of inhaler lavender, focus and music on women's pain and anxi.ety in intrauterine device application.

In the randomized controlled experimental study, data would be obtained using the Numerical Anxiety Rating Scale and the Numerical Pain Rating Scale. 240 women who underwent IUD procedure at the Family Planning Consultancy Polyclinic of a secondary level public hospital in a city center between October and December 2023 were randomly assigned to receive 4 sets of 1 set of Inhaled lavender (60), 1 set of Focusing (60), 1 set of Music ( 60). 1 control group (60) will participate in the study.

Condition or Disease Intervention/Treatment Phase
  • Other: inhaled lavender
  • Other: Working Group 2: Focusing
  • Other: Working Group 3 music
N/A

Detailed Description

The rate of women who want to use Family Planning in the world has reached approximately 1.1 billion in the last twenty years and has shown a significant increase ( WHO, 2020) . In addition, WHO reported that almost half of the pregnancies in developing countries between 2015 and 2019 were unwanted pregnancies (WHO, 2020) , and recommended effective FP counseling and the use of more modern contraceptive methods to prevent this (WHO, 2020) . In Turkey, the Ministry of Health provides individuals with free access to modern FP methods. Despite this, according to the 2018 data of the Turkey Demographic and Health Survey ( Akdemir and Karadeniz 2019), it has been reported that 49% of the FP method uses modern methods and the Intrauterine Device (IUD) is among the most effective modern methods with a rate of 14% (Akdemir and Karadeniz 2019 ). Factors affecting IUD use include; Women's perception of pain during application and the fact that it can be applied in certain centers (Dine et al,2018; Hunter et al, 2020; Hamdamian et al., 2018).

It has been reported in the literature that women perceive pain during IUD application (Akdemir and Karadeniz 2019; Dine et al,2018; Hunter et al, 2020; Hamdamian et al., 2018). Again, studies have reported the use of inhaled lavender, focus, and music to relieve pain and anxiety (Hamdamian et al., 2018; Hathcock et al., 2021; Türkmen et al.,2021) . These results emphasize the need for low-cost and applicable nonpharmacological methods for healthcare professionals during IUD insertion.

No study has been found in the literature examining the effects of inhaler lavender, focus and music on women's pain and anxiety during intrauterine device application. However, in line with the results of the study, it is thought that it will have a positive effect on reducing the pain and anxiety perceived by women during the IUD procedure.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
240 participants
Allocation:
Randomized
Intervention Model:
Sequential Assignment
Intervention Model Description:
In our research, there will be 3 interventions (Group 1 is a focus group, Group 2 is the Group where inhaled kavanta is used, Group 3 will be listened to music) and 1 control group (The group where IIA is applied and receives routine care). .In our research, there will be 3 interventions (Group 1 is a focus group, Group 2 is the Group where inhaled kavanta is used, Group 3 will be listened to music) and 1 control group (The group where IIA is applied and receives routine care). .
Masking:
Triple (Care Provider, Investigator, Outcomes Assessor)
Masking Description:
PERSON USING IUD. IT WILL ALWAYS BE THE SAME AND THERE WILL BE ONE PERSON WHO HAS NOTHING TO DO WITH THE RESEARCH. THE RESEARCHER WILL HAVE NO INTERVENTION DURING IUD APPLICATION.
Primary Purpose:
Supportive Care
Official Title:
"The Effect of Inhaler Lavender, Focus and Music on Women's Pain, Anxiety, in Intrauterine Device Application"
Actual Study Start Date :
Oct 19, 2023
Anticipated Primary Completion Date :
Dec 30, 2023
Anticipated Study Completion Date :
Dec 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Working Group 1(inhaled lavender)

In study group 1, 3 drops of lavender oil will be dropped on aromastone and participants will be asked to inhale deeply 10 times. Then, participants will be allowed to inhale lavender oil for a total of 30 minutes in the waiting room where aromastone is located and in the ria application room.

Other: inhaled lavender
They will be asked to inhale deeply 10 times. Then, a total of 30 minutes in the waiting room where aromastone is located and in the IA application room.

Experimental: Working Group 2: Focusing

After the internet connection is established with the smartphone, you can click on www.youtube.com and watch the "Relaxation Project 1" (SBS VR) video for the image and ask to focus.

Other: Working Group 2: Focusing
During IUD application

Experimental: Working Group 3 music

You will be able to listen to Turkish classical music for a total of 30 minutes in the RIA application waiting room and RIA application room.

Other: Working Group 3 music
for a total of 30 minutes
Other Names:
  • music
  • No Intervention: Control Group

    The care and practices will be the same as in routine IUD application.

    Outcome Measures

    Primary Outcome Measures

    1. Numerical Pain Rating Scale Pain [Procedure (Speculum insertion)]

      Numerical Pain Assessment Scale Pain (NADÖ): Numerical Pain Assessment Scale (NADÖ) is used to evaluate the severity of pain. On the numerical rating scale, pain ranges from 0 (absence of pain) to 10 (unbearable pain).

    2. Numerical Pain Rating Scale Pain [up to 10 minutes (During the Pap smear test)]

      Numerical Pain Assessment Scale Pain (NADÖ): Numerical Pain Assessment Scale (NADÖ) is used to evaluate the severity of pain. On the numerical rating scale, pain ranges from 0 (absence of pain) to 10 (unbearable pain).

    3. Numerical Pain Rating Scale Pain [15 minutes after the Pap smear test.]

      Numerical Pain Assessment Scale Pain (NADÖ): Numerical Pain Assessment Scale (NADÖ) is used to evaluate the severity of pain. On the numerical rating scale, pain ranges from 0 (absence of pain) to 10 (unbearable pain).

    4. The Verbal Category Scale [Procedure (Speculum insertion)]

      The Verbal Category Scale is also called the Simple Descriptive Scale, and this scale is based on the patient choosing the most appropriate word that describes the pain condition. Pain intensity ranges from mild to unbearable. In this scale, the words "mild", "disturbing", "severe", "very severe", "unbearable" were used to describe the intensity of pain (

    5. The Verbal Category Scale [up to 10 minutes (During the Pap smear test)]

      The Verbal Category Scale is also called the Simple Descriptive Scale, and this scale is based on the patient choosing the most appropriate word that describes the pain condition. Pain intensity ranges from mild to unbearable. In this scale, the words "mild", "disturbing", "severe", "very severe", "unbearable" were used to describe the intensity of pain (

    6. The Verbal Category Scale [15 minutes after the Pap smear test.]

      The Verbal Category Scale is also called the Simple Descriptive Scale, and this scale is based on the patient choosing the most appropriate word that describes the pain condition. Pain intensity ranges from mild to unbearable. In this scale, the words "mild", "disturbing", "severe", "very severe", "unbearable" were used to describe the intensity of pain (

    7. Numerical Rating Scale for Anxiety (VASA). [5 minutes]

      Numerical Rating Scale for Anxiety (VASA). It is expressed as whether the individual feels anxiety (e.g., I have a lot of anxiety = 10) or does not feel anxiety (e.g., I have no anxiety = 0).

    8. Numerical Rating Scale for Anxiety (VASA). [2 minutes]

      Numerical Rating Scale for Anxiety (VASA). It is expressed a Outcome 8s whether the individual feels anxiety (e.g., I have a lot of anxiety = 10) or does not feel anxiety (e.g., I have no anxiety = 0).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Being between the ages of 18-45,

    • having IUD applied for the first time,

    • being literate in Turkish,

    • having no history of cervical surgery,

    • having no active mental illness,

    • having no pain before IUD application.

    Exclusion Criteria:
    • Having communication problems,

    • visual or auditory disabilities,

    • use of misoprostol during the procedure,

    • use of painkillers before the IUD application procedure,

    • use of medication for anxiety before the procedure.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 TurkishMoHKahramanmarasPH Kahramanmaraş Turkey 46050

    Sponsors and Collaborators

    • Turkish Ministry of Health, Kahramanmaras Provincial Health Directorate

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    Responsible Party:
    Mine Gokduman Keles, Midwifery, Turkish Ministry of Health, Kahramanmaras Provincial Health Directorate
    ClinicalTrials.gov Identifier:
    NCT06110871
    Other Study ID Numbers:
    • TurkishHKahramanmaras
    First Posted:
    Nov 1, 2023
    Last Update Posted:
    Nov 1, 2023
    Last Verified:
    Oct 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Mine Gokduman Keles, Midwifery, Turkish Ministry of Health, Kahramanmaras Provincial Health Directorate

    Study Results

    No Results Posted as of Nov 1, 2023